Prevalence of Helicobacter pylori among Sudanese patients diagnosed with colon polyps and colon cancer using immunohistochemistry technique.

doi:10.21203/rs.3.rs-31738/v3

Download PDF

Research note

Prevalence of Helicobacter pylori among Sudanese patients diagnosed with colon polyps and colon cancer using immunohistochemistry technique.

https://doi.org/10.21203/rs.3.rs-31738/v3

This work is licensed under a CC BY 4.0 License

Journal Publication

published 06 Jul, 2020

Read the published version in BMC Research Notes →

You are reading this latest preprint version

Objectives: Infection with the bacteria Helicobacter pylori has been classified as class one carcinogen associated with increasing susceptibility of gastritis and gastric carcinoma. This study is aiming at investigating the prevalence of H. pylori among colon polyps and colon cancer patients. A descriptive cross-sectional hospital-based study was conducted between February and June 2017. Sixty-nine formalin-fixed paraffin blocks collected from colon polyps and colon cancer patients to detect H. pylori using immunohistochemistry technique.

Results: Of the Sixty-nine patients included in the study, 39 (56.5%) males and 30 (43.5%) were females, their age ranged from 21 to 80 years with a mean age of 47.1±19.7. Of the 69 colon polyps and colon cancer patients, 44 (63.8%) were diagnosed as adenocarcinoma, 10 (14.5%) colitis, 15 (21.7%) juvenile polyposis syndrome. The results of immunohistochemistry technique showed the presence of 16 (23.2%) positive patients for H. pylori infection. Of these 16, 13 (81.3%) patients were diagnosed with adenocarcinoma and 3 (18.7%) patients were diagnosed with juvenile polyps. The results of H. pylori detection among the different colon polyps and colon cancer patients were showing a statistically significant association for H. pylori infection and adenocarcinoma, P value 0.028.

Cancer Biology

Colon polyps

Colon cancer

Helicobacter pylori

Immunohistochemistry

Colorectal cancer (CRC) is accounted as the third most common malignancy and the third most common cause of death due to cancer in both men and women in the US [1]. CRC mostly arises from adenomatous polyps (adenomas) and from hyperplastic polyps [2, 3]. Early diagnosis and surgical removal of these polyps have associated with the decreased in the incidence of mortality [4-6]. Therefore, clinicians started to focus in recent years on the prevention measures that decrease the incidence of developing CRC; although, researchers started to explore the role of several infectious organism and their ability to increase or induce CRC [7-10]. For instance, many epidemiological studies have linked the infection of Helicobacter pylori to colorectal neoplasm either through high prevalence of H. pylori seropositivity among CRC or colorectal polyp patients [11-14], or through the presence of bacterial products and their trophic effects on colon mucosa [15-18]. Moreover, few studies have linked the presence of H. pylori in the stomach or colon with colon cancer and/or polyps [19-24].

It is well known that H. pylori predisposes to develop gastric cancer precursor lesions, thus it has been classified as class 1 carcinogen [25]. A recent meta-analysis correlating between H. pylori and extra-gastric malignancies revealed a statistically significant relationship of H. pylori infection with both colon cancer and polyps [26]. Also, H. pylori infection linked with colorectal lesions appeared to be more common in African Americans compared to the Caucasian population in the US [27, 28].

Epidemiological studies have confirmed a causal relationship between H. pylori and gastric cancer, and the colonic phenotype of H. pylori-related intestinal metaplasia (IM) [29]. Thus, association of H. pylori in various gastrointestinal cancers has been investigated, moreover, Helicobacter DNAs were prevalent in more than 50 percent of hepatobiliary cancer cases [30]. Helicobacter species, which may colonize the biliary tract, have been implicated as a possible cause of hepatobiliary diseases ranging from chronic cholecystitis and primary sclerosing cholangitis to gall-bladder carcinoma and primary hepatic carcinomas [31]. Therefore, the hypothesis that H. pylori would also be associated with colon lesions needs to be investigated. In Sudan, no reports addressing this manner were existed. Previous studies investigating the seroprevalence of H. pylori among Sudanese using ELISA and rapid immunochromatographic tests for the detection of H. pylori IgM and IgG antibodies, reported a seroprevalence ranging from 20% up to 70% [32-35]. Therefore, the aim of this study was to investigate the presence of H. pylori infections among Sudanese patients diagnosed with colon polyps and colon cancer and to correlate between its presence and the type of the lesions.

Sample and data collection

This is a preliminary, descriptive study aimed to investigate the frequency of H. pylori infections among Sudanese patients diagnosed with colon cancer. Data were collected from 69 patients attended the National Laboratory and Alrahma Laboratory between February-June 2017.

During colonoscopy, presence of abnormal tissue, such as clumps of cells; polyps, formed on the inside of the colon, the pathologists obtained colon biopsies. Colon biopsies were fixed with formalin and processed into paraffin embedded blocks. Formalin-fixed paraffin blocks were used for the immunohistochemical detection of H. pylori. Ethical approval was previously obtained by the pathologists of each hospital before colon polyps’ biopsies were taken.

Preparation of the formalin fixed paraffin blocks

Four sections from each formalin-fixed paraffin block to increase detection sensitivity were obtained with a thickness of 4µm using Rotary microtome (LEICA RM2125RT). All sections were de-waxed with two changes of Xylene for 3 minutes and then dehydrated in descending concentrations of Methanol starting from absolute Methanol through 90% and lastly, a concentration of 70% for 2 minutes in each concentration, and then washed using distilled water.

Immunohistochemistry diagnosis

Immunohistochemistry diagnosis was performed on all the obtained sections. Known gastric sections containing H. pylori infection was used as positive and negative controls; for the negative control the primary antibody incubation step was omitted. All sections were pretreated to retrieve antigens at 97^oC for 10 minutes in citrate buffer solution, and then sections were blocked by 3% Hydrogen peroxide and absolute Methanol for 20 minutes at humidified chamber. Afterward, sections were blocked into Bovine serum Albumin (Thermo Fisher Scientific, Germany). A rabbit polyclonal antibody ULC3R (BioGenex, USA) (prepared from tissue culture supernatant diluted in PBS, pH 7.6 containing 5% BSA and 0.09% Sodium Azaide) against H. pylori was applied for 40 minutes, then washed in buffer solution for 5 minutes. Then, a polymer solution was applied for 15 minutes, and washed in buffer solution for 5 minutes. Chromogen solution was added for 10 minutes, and washed in distilled water. Finally, Mayer’s Hematoxylin was added for 2 minutes, and then, sections were blued using running distilled water for 5 minutes. After bluing, sections were dehydrated, cleared, and mounted in DPX. Prepared sections were investigated microscopically by two experts’ pathologists blindly without knowing the duplication of slides sections of each patient using X40 lens. Results were recorded into categories of positive and negative results; the dot like shape denoted the coccoid form of the organism as describe previously [36-39].

Statistical analysis:

Descriptive data were analyzed using the Statistical Package for Social Science (SPSS-v20). Pearson Chi-square test was used to test the association of H. pylori infection with the different types of lesions. A P value < 0.05 was considered as a statistically significant.

Of the 69 patients, there were 30 (43.5%) females and 39 (56.5%) males, their ages ranged from 21 to 80 years with a mean age 47.1±19.8. 44 (63.8%) patients were diagnosed with adenocarcinoma, 10 (14.5%) patients were colitis, and 15 (21.7%) patients were juvenile polyposis syndrome. No statistically significant was observed for the association of gender and the pathological condition of each patient, P value = 0.649. Out of the 69 patients, 16 (23.2%) patients were positive for H. pylori infection. These 16 positive patients included; 13 (81.3%) patients diagnosed with adenocarcinoma and 3 (18.7%) patients diagnosed with juvenile polyps. The correlation between presence of H. pylori infection and the histopathological condition of patients were positively correlated (P value 0.028) (Table 1).

In respect to Immunohistochemistry diagnosis, the bacteria were prominent and easier to detect in the immune-stained sections in several patterns including organisms attached to the epithelial cells or within the superficial mucus. And in some cases, the bacteria were masked by inspissated mucus or being positioned flat and closely opposed to the epithelial surface. Regarding the morphological appearance of the organism; H. pylori stained brown in color and take a dot and small curved shape in different sizes (Figure 1).

The exact role of H. pylori in the induction of colon cancer is still a debate between the scientific researcher communities; this is attributed to the controversial results obtained. In previous studies, H. pylori were linked to the development of gastric cancer [40], while others reported paradoxical results showing no association between H. pylori and gastric cancer susceptibility [41-43]. However, reports from Sudan regarding the possible link between H. pylori and colon cancer are scarce. Therefore, in the present study, we examined the presence of H. pylori using immunohistochemistry technique on colon polyps and colon cancer lesions of Sudanese patients underwent colonoscopy.

The results obtained from this study showed a positive correlation between the presence of H. pylori infection and the histopathological diagnosis, as H. pylori was prevalent in higher frequency in patients diagnosed with adenocarcinoma compared to those diagnosed as juvenile polyposis syndrome, and the result was statistically significant. This result also agrees with studies conducted by Jones et al, and Grahn et al., they investigated the presence of H. pylori among 59 patients diagnosed with colon adenocarcinomas using immunohistochemistry technique, and 77 colon and rectum cancer patients using molecular technique, correspondingly [44, 45]. Jones et al., reported that H. pylori were detected in 10/59 adenocarcinoma cases which represent about 16.9% of the total cancer cases studied [44]. While, Grahn et al., showed that H. pylori were present in 27% of the patients; among the studied colon cancer, H. pylori were present in 11/42 (26%) patients [45].

Although, several studies failed to demonstrate any association between H. pylori and colon cancer, or even if this microorganism can colonize the colon [46-50]. This could only be attributed to the ability of demonstrating the H. pylori bacteria, which was achieved by the aid of the immunohistochemistry technique that allowed a better localization of H. pylori within the various colon lesions of colitis, polyps, and adenocarcinoma included in this study.

Interestingly, several theories were proposed regarding the exact role by which H. pylori induced colon cancer, one hypothesis is that colon cancer can be induced by toxins produced by H. pylori; however, this theory was based only on serological data [43, 51-53]. Furthermore, some studies showed that colitis and colon cancer were also developed in experimental mice models infected with H. hepaticus [54]. Accordingly, the development of colon cancer seems most likely due to the interaction between toxins produced by the bacteria and the immune cells of the mice [54]. Therefore, the results we obtained from our study showing that H. pylori were present, nevertheless, it means that H. pylori infection is responsible for the induction and the development of colon cancer, since the presence of H. pylori could be encountered as post-cancer incidence. This however, still requires more complicated experimental studies to investigate this hypothesis; yet, the role of H. pylori cannot be excluded due to this hypothesis. Therefore, this preliminary report needs further advanced experimental investigations to enable the determination on the exact mechanisms by which H. pylori can induce colon cancer.

This study was able to demonstrate the presence of H. pylori in colon polyps and colon cancer using immunohistochemistry marker, besides the significant association in the presence of H. pylori with colon adenocarcinoma, indeed further studies are required to elaborate more in-depth about the exact role of H. pylori in the development of colon cancer.

In this study the sample size studied was relatively small, but still a significant association was observed. A bigger sample size of colon cancer lesions and benign colon lesions; non cancer lesions, should be included in future studies to determine the significant association of H. pylori with adenocarcinoma among the Sudanese patients diagnosed with colon cancer.

DNA: Deoxyribonucleic acid; CRC: Colorectal cancer; IM: Intestinal Metaplasia.

Ethics approval and consent to participate

The study ethical clearance was obtained from University of Khartoum, Faculty of Medical Laboratory Sciences ethical review board. Informed consent was obtained from each participant prior to enrollment using writing and verbal informed consent.

Consent to publish

Not Applicable.

Availability of Data and Materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors declare that they have no competing interests.

Funding

Not Applicable.

Authors' contributions

AKM, NME, ZAA, FSA, EES and AMME provided conceptual framework for the project. AKM, NME, ZAA, FSA, ETA, NAM, RH, HAO and ESA participated in the preparation of the samples and performed the diagnosis. NSM, AF, EES, MSM, AA, and AMME performed the data analysis and guidance for data interpretation. AA, MSM, ETA, NAM, RH, ESA, AF, and NSM drafted the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors are grateful to the patients and the staff at the National Laboratory and Al-Rahma Laboratory for their continued collaboration and generous hospitality.

Author’s Information

Aziza K. Mohamed

1 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan. Email: [email protected].

Nazik M. Elhassan

1 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan. Email: [email protected].

Zahra A. Awhag

1 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan. Email: [email protected].

Fadwa S. Ali

1 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan. Email: [email protected].

Eman T. Ali

1 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan.

2 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, National University, Sudan, Khartoum, Sudan. Email: [email protected].

Najwa A. Mhmoud

3 Mycetoma research center, Khartoum, Sudan.

4 Department of Microbiology and immunology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan. Email: [email protected].

Emmanuel E. Siddig

3 Mycetoma research center, University of Khartoum, Khartoum, Sudan.

5 Nile University, School of medicine, Khartoum, Sudan.

6 Department of Histopathology and Cytology, Alfarrabi College for Science and Technology, Khartoum, Sudan. Email: [email protected].

Rowa Hassan

3 Mycetoma Research Center, University of Khartoum, Khartoum, Sudan. Email: [email protected].

Eiman S. Ahmed

3 Mycetoma Research Center, University of Khartoum, Khartoum, Sudan. Email: [email protected].

Azam Fattahi

7 Center for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran, Iran. Email: [email protected].

Ayman Ahmed

8 Department of Parasitology and Medical Entomology, Institute of Endemic Diseases, University of Khartoum, Sudan. Email: [email protected]

Mohamed S. Muneer

9 Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.

10 Department of Radiology, Mayo Clinic, Jacksonville, FL, USA

11 Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan. Email: [email protected]

Hussam A. Osman

12 Biomedical Research Laboratory, Ahfad University for Women, Omdurman, Sudan.

Email: [email protected]

Nouh S. Mohamed

12 Molecular Biology Department, Biotechnology Lab, Faculty of Pharmacy. Ahfad University for women, Khartoum Sudan.

13 Department of Parasitology and Medical Entomology, Faculty of Medicine, Sinnar University, Sinnar, Sudan.

14 Department of Parasitology and Medical Entomology, Faculty of Medical Laboratory Sciences, Nile University, Khartoum, Sudan. Email: [email protected].

Ali MM. Edris

1 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan.

15 Faculty of Applied Medical Sciences, University of Bisha, Bisha, Kingdom of Saudi Arabia. Email: [email protected].

Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA: a cancer journal for clinicians 2010, 60:277-300.
Hawkins NJ, Ward RL: Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. Journal of the National Cancer Institute 2001, 93:1307-1313.
Jass JR: Hyperplastic-like polyps as precursors of microsatellite-unstable colorectal cancer. American journal of clinical pathology 2003, 119:773-775.
Kahi CJ, Imperiale TF, Juliar BE, Rex DK: Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clinical gastroenterology hepatology 2009, 7:770-775.
Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: a cancer journal for clinicians 2008, 58:130-160.
Winawer SJ, Zauber AG, Ho MN, O'brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF: Prevention of colorectal cancer by colonoscopic polypectomy. New England Journal of Medicine 1993, 329:1977-1981.
Burnett-Hartman AN, Newcomb PA, Potter JD: Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiology Prevention Biomarkers 2008, 17:2970-2979.
Meira LB, Bugni JM, Green SL, Lee C-W, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, McFaline JL: DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. The Journal of clinical investigation 2008, 118:2516-2525.
Parsonnet J: Bacterial infection as a cause of cancer. Environmental health perspectives 1995, 103:263-268.
Dejea C, Wick E, Sears CL: Bacterial oncogenesis in the colon. Future microbiology 2013, 8:445-460.
Fujimori S, Kishida T, Kobayashi T, Sekita Y, Seo T, Nagata K, Tatsuguchi A, Gudis K, Yokoi K, Tanaka N: Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. Journal of gastroenterology 2005, 40:887-893.
Fujimori S, Kishida T, Kobayashi T, Sekita Y, Seo T, Nagata K, Tatsuguchi A, Gudis K, Yokoi K, Tanaka NJJog: Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. 2005, 40:887-893.
Zhao Y-s, Wang F, Chang D, Han B, You D-y: Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. International journal of colorectal disease 2008, 23:875-882.
Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M, Nieters A, Rothenbacher D: Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany. European Journal of Cancer 2007, 43:1283-1289.
D'Onghia V, Leoncini R, Carli R, Santoro A, Giglioni S, Sorbellini F, Marzocca G, Bernini A, Campagna S, Marinello E: Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomedicine Pharmacotherapy 2007, 61:137-141.
Georgopoulos SD, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis DG, Ladas SD: Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion 2006, 74:42-46.
Hartwich A, Konturek S, Pierzchalski P, Zuchowicz M, Labza H, Konturek P, Karczewska E, Bielanski W, Marlicz K, Starzynska T: Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. International journal of colorectal disease 2001, 16:202-210.
Siddheshwar R, Gray J, Kelly S: Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut 2001, 48:47-52.
Bae RC, Jeon SW, Cho HJ, Jung MK, Kweon YO, Kim SK: Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm. World Journal of Gastroenterology: WJG 2009, 15:5722.
Bulajic M, Stimec B, Ille T, Jesenofsky R, Kecmanovic D, Pavlov M, Ceranic M, Schneider-Brachert W, Lowenfels A, Maisonneuve P: PCR detection of helicobacter pylori genome in colonic mucosa: normal and malignant. Prilozi 2007, 28:25-38.
Grahn N, Hmani-Aifa M, Fransén K, Söderkvist P, Monstein H-J: Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. Journal of medical microbiology 2005, 54:1031-1035.
Jones NL, Day AS, Jennings HA, Sherman PM: Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infection immunity 1999, 67:4237-4242.
Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A: Helicobacter pylori infection is associated with colon adenomatous polyps detected by high‐resolution colonoscopy. International journal of cancer 2005, 117:1058-1059.
Soylu A, Ozkara S, Alıs H, Dolay K, Kalaycı M, Yasar N, Kumbasar AB: Immunohistochemical testing for Helicobacter Pylori existence in neoplasms of the colon. BMC gastroenterology 2008, 8:35.
Bulajic M, Stimec B, Jesenofsky R, Kecmanovic D, Ceranic M, Kostic N, Schneider-Brachert W, Lowenfels A, Maisonneuve P, Löhr J-M: Helicobacter pylori in colorectal carcinoma tissue. Cancer Epidemiology Prevention Biomarkers 2007, 16:631-633.
Rokkas T, Sechopoulos P, Pistiolas D, Kothonas F, Margantinis G, Koukoulis G: The relationship of Helicobacter pylori infection and colon neoplasia, on the basis of meta-analysis. European journal of gastroenterology hepatology 2013, 25:1286-1294.
Jemal A, Siegel R, Xu J, Ward EJCacjfc: Cancer statistics, 2010. 2010, 60:277-300.
Malaty HM, Evans DG, Evans Jr DJ, Graham DY: Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology 1992, 103:813-816.
Alfarouk KO, Bashir AH, Aljarbou AN, Ramadan AM, Muddathir AK, AlHoufie ST, Hifny A, Elhassan GO, Ibrahim ME, Alqahtani SS: The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management. Frontiers in oncology 2019, 9:75.
Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, Furui J, Kanematsu T: Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 2002, 23:1927-1932.
Leong R, Sung J: Helicobacter species and hepatobiliary diseases. Alimentary pharmacology therapeutics 2002, 16:1037-1045.
Salih KM, Elfaki OA, Hamid YH, Eldouch WM, Diab M, Abdelgadir SO: Prevalence of Helicobacter Pylori among Sudanese children admitted to a specialized children hospital. Sudanese journal of paediatrics 2017, 17:14.
Abdallah TM, Mohammed HB, Mohammed MH, Ali AAA: Sero-prevalence and factors associated with Helicobacter pylori infection in Eastern Sudan. Asian Pacific journal of tropical disease 2014, 4:115-119.
Abbas M, Sharif FA, Osman SM, Osman AM, El Sanousi SM, Magzoub M, Ibrahim ME: Prevalence and Associated Symptoms of Helicobacter pylori Infection among Schoolchildren in Kassala State, East of Sudan. Interdisciplinary perspectives on infectious diseases 2018, 2018.
Osman NA, Ahmed AA, Ahmed M, Osman T: Seroprevalence of Helicobacter pylori among Sudanese Gastritis Patients. African Journal of Medical Sciences 2016, 1.
Chan W-Y, Hui P-K, Leung K-M, Chow J, Kwok F, Ng C-S: Coccoid forms of Helicobacter pylori in the human stomach. American journal of clinical pathology 1994, 102:503-507.
Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, Guadagnini S, Prévost M-C, Mengin-Lecreulx D, Labigne A, Boneca IG: Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS pathogens 2006, 2:e97.
Saito N, Oda H, Sato F, Kato M, Takeda H, Sugiyama T, Asaka M: Ultrastructure of helicobacter pylori. Journal of Gastroenterology Hepatology 2000, 15:H25-H25.
Ali ET, Fadul TM, Nasr MA, Siddig EE, Mohamed NS, Edris AMM: Comparison Between Immunohistochemical Marker and Conventional Histochemical Stains in Detecting Helicobacter pylori. EC MICROBIOLOGY 2018.
Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J: Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World journal of surgical oncology 2007, 5:51.
Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J: Relationship between Helicobacter pylori CagA status and colorectal cancer. The American journal of gastroenterology 2001, 96:3406.
Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A: Helicobacter pylori: seroprevalence and colorectal cancer. The Israel Medical Association journal: IMAJ 2000, 2:6-9.
Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui AJIjoc: Helicobacter pylori infection is associated with colon adenomatous polyps detected by high‐resolution colonoscopy. 2005, 117:1058-1059.
Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew JJWjoso: Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? 2007, 5:51.
Grahn N, Hmani-Aifa M, Fransén K, Söderkvist P, Monstein H-JJJomm: Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. 2005, 54:1031-1035.
Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, Virtamo J, Albanes D: Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiology Prevention Biomarkers 2002, 11:1095-1099.
Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA: Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. JNCI: Journal of the National Cancer Institute 1995, 87:762-763.
Siddheshwar R, Muhammad K, Gray J, Kelly S: Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. The American journal of gastroenterology 2001, 96:84.
Luzza F, Maletta M, Imeneo M, Monteleone G, Marasco R, Biancone L, Pallone F: Evidence against colonic mucosa colonisation by Helicobacter pylori. Lack of a specific antibody response in homogenates of rectal endoscopic biopsies. The Italian journal of gastroenterology 1996, 28:447-451.
Bell S, Chisholm S, Owen R, Borriello S, Kamm M: Evaluation of Helicobacter species in inflammatory bowel disease. Alimentary pharmacology therapeutics 2003, 18:481-486.
Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav JJTAjog: Relationship between Helicobacter pylori CagA status and colorectal cancer. 2001, 96:3406.
Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg AJTIMAjI: Helicobacter pylori: seroprevalence and colorectal cancer. 2000, 2:6-9.
Hsu W-Y, Lin C-H, Lin C-C, Sung F-C, Hsu C-P, Kao C-H: The relationship between Helicobacter pylori and cancer risk. European journal of internal medicine 2014, 25:235-240.
Bell S, Chisholm S, Owen R, Borriello S, Kamm MJAp, therapeutics: Evaluation of Helicobacter species in inflammatory bowel disease. 2003, 18:481-486.

Table 1: Shows the correlation between gender, immunohistochemistry detection of H. pylori with the histopathological diagnosis.

	Histopathological Diagnosis			Total	P value
	Adenocarcinoma	Juvenile Polyposis Syndrome	Colitis	Total	P value
Gender
Male	23 (58.9%)	10 (25.6%)	6 (15.5%)	39 (56.5%)	0.649
Female	21 (70.0%)	5 (16.7%)	4 (13.3%)	30 (43.5%)
Total	44 (63.8%)	15 (21.7%)	10 (14.5%)	69 (100%)
Immunohistochemistry of H. Pylori
Negative	31 (58.5%)	12 (22.6%)	10 (18.9%)	53 (76.8%)	0.028
Positive	13 (81.3%)	3 (18.7%)	0 (0.0%)	16 (23.2%)
Total	44 (63.8%)	15 (21.7%)	10 (14.5%)	69 (100%)

Download PDF

Journal Publication

published 06 Jul, 2020

Read the published version in BMC Research Notes →

Submission checks completed at journal
25 Jun, 2020
Editorial decision: Accept
25 Jun, 2020

You are reading this latest preprint version

Prevalence of Helicobacter pylori among Sudanese patients diagnosed with colon polyps and colon cancer using immunohistochemistry technique.

Status:

Journal Publication

Version 3

Abstract

Figures

Introduction

Materials And Methods

Results

Discussion

Conclusion

Limitations

Abbreviations

Declarations

Ethics approval and consent to participate

Consent to publish

Availability of Data and Materials

Competing interests

Funding

Authors' contributions

Acknowledgements

Author’s Information

References

Table

Status:

Journal Publication

Version 3